20/20 Biolabs, Inc. 8-K

What Happened 20/20 Biolabs, Inc. (ticker: AIDX) filed a Form 8‑K on July 1, 2026 to furnish an investor presentation that the company intends to use in an investor webinar on July 1, 2026. The filing is made under Item 7.01 (Regulation FD Disclosure) and attaches the presentation as Exhibit 99.1. The company states that furnishing the materials is not intended to represent that the disclosure is required by Regulation FD or other securities laws and that it does not assume any obligation to update the information.

Key Details

• Filing date: July 1, 2026; Item 7.01 Regulation FD Disclosure.
• Exhibit attached: Investor Presentation, dated July 2026 (Exhibit 99.1).
• Company disclaimer: Furnishing is not a representation that disclosure is required by Reg FD and the company has no obligation to update the materials.
• No earnings, financial results, executive changes, or other material events were reported in this filing.

Why It Matters This filing notifies investors that 20/20 Biolabs is publicly sharing an investor presentation in a live webinar; investors should review the presentation for any operational or strategic updates. However, the 8‑K clarifies the company is furnishing (not formally disclosing) the materials under Reg FD language and is not committing to update them—so any material financial results or formal disclosures would still need to be made through the company’s regular SEC filings.